2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Clinical trial NCT00223977 · COMPLETED

Trial details

NCT number: NCT00223977
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Iron Deficiency Anemia

Start date: 2003-12-01
Primary completion: 2004-11-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.